# METHOTREXATE

NDC: 62332-712
Generic name: methotrexate
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20260415

FDA application: ANDA220225

## Active ingredients

- METHOTREXATE SODIUM: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-712"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-712
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a63364d5-4dfa-49d7-8a5e-c8959ae1d37a
